Acorda Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
21 Dec 2018	Form 4/A: Sabella Lauren M, Chief Commercial Officer Sold 3,774 shares ($105K)
13 Mar 2008	Form 4/A: Cohen Ron, President and CEO Sold 2,500 shares ($43.9K)
24 Jan 2008	Form 4/A: Blight Andrew, Chief Scientific Officer Received 3,366 shares by exercise or conversion ($8.75K) · Sold 3,366 shares ($68.2K)
24 Jan 2008	Form 4/A: Blight Andrew, Chief Scientific Officer Received 3,044 shares by exercise or conversion ($7.91K) · Sold 3,044 shares ($54.9K)
18 Jun 2007	Form 4/A: Lawrence David, Chief Financial Officer Sold 5,941 shares ($117K)
15 Jun 2007	Form 4/A: Blight Andrew, Chief Scientific Officer Received 641 shares by exercise or conversion ($1K) · Sold 641 shares ($12.5K)
14 Jun 2007	Form 4/A: Panem Sandra Phd, Director Sold 7,500 shares ($176K)
06 Mar 2007	Form 4/A: Panem Sandra Phd, Director Sold 7,500 shares ($176K) · Disposed of 1,178 shares (Other Transaction)
03 Nov 2006	Form 4/A: Cohen Ron, Director Sold 22,000 shares ($358K)
03 Nov 2006	Form 4/A: Cohen Ron, Director Sold 28,000 shares ($462K)
03 Nov 2006	Form 4/A: Cohen Ron, Director Sold 14,020 shares ($237K)
03 Nov 2006	Form 4/A: Cohen Ron, Director Sold 35,980 shares ($620K)

Comments